Does volume change of the spleen correlate with the therapy response in uveal melanoma patients with liver metastases undergoing hepatic artery infusion chemotherapy?

1. Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD. Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol 2017; 101: 38-44. doi: doi: 10.1136/bjophthalmol-2016-309034 Carvajal RD Schwartz GK Tezel T Marr B Francis JH Nathan PD. Metastatic disease from uveal melanoma: treatment options and future prospects . Br J Ophthalmol 2017 ; 101 : 38 - 44 . 10.1136/bjophthalmol-2016-309034 Open DOISearch in Google Scholar

2. Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 2011; 118: 1881-5. doi: 10.1016/j.ophtha.2011.01.040 Singh AD Turell ME Topham AK. Uveal melanoma: trends in incidence, treatment, and survival . Ophthalmology 2011 ; 118 : 1881 - 5 . 10.1016/j.ophtha.2011.01.040 Open DOISearch in Google Scholar

3. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol 2005; 23: 8076-80. doi: 10.1200/JCO.2005.02.6534 Rietschel P Panageas KS Hanlon C Patel A Abramson DH Chapman PB. Variates of survival in metastatic uveal melanoma . J Clin Oncol 2005 ; 23 : 8076 - 80 . 10.1200/JCO.2005.02.6534 Open DOISearch in Google Scholar

4. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol 2005; 123: 1639-43. doi: 10.1001/archopht.123.12.1639 Diener-West M Reynolds SM Agugliaro DJ Caldwell R Cumming K Earle JD Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26 . Arch Ophthalmol 2005 ; 123 : 1639 - 43 . 10.1001/archopht.123.12.1639 Open DOISearch in Google Scholar

5. Nathan P, Cohen V, Coupland S, Curtis K, Damato B, Evans J, et al. Uveal Melanoma UK National Guidelines. Eur J Cancer 2015; 51: 2404-12. doi: 10.1016/j.ejca.2015.07.013 Nathan P Cohen V Coupland S Curtis K Damato B Evans J Uveal Melanoma UK National Guidelines . Eur J Cancer 2015 ; 51 : 2404 - 12 . 10.1016/j.ejca.2015.07.013 Open DOISearch in Google Scholar

6. Hassel JC, Piperno-Neumann S, Rutkowski P, Baurain J-F, Schlaak M, Butler MO, et al. Three-year overall survival with tebentafusp in metastatic uveal melanoma. N Engl J Med 2023; 389: 2256-66. doi: doi: 10.1056/NEJMoa2304753 Hassel JC Piperno-Neumann S Rutkowski P Baurain J-F Schlaak M Butler MO Three-year overall survival with tebentafusp in metastatic uveal melanoma . N Engl J Med 2023 ; 389 : 2256 - 66 . 10.1056/NEJMoa2304753 Open DOISearch in Google Scholar

7. Buder K, Gesierich A, Gelbrich G, Goebeler M. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med 2013; 2: 674-86. doi: 10.1002/cam4.133 Buder K Gesierich A Gelbrich G Goebeler M. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives . Cancer Med 2013 ; 2 : 674 - 86 . 10.1002/cam4.133 Open DOISearch in Google Scholar

8. Schelhorn J, Richly H, Ruhlmann M, Lauenstein TC, Theysohn JM. A singlecenter experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma. Acta Radiol Open 2015; 4: 2047981615570417. doi: 10.1177/2047981615570417 Schelhorn J Richly H Ruhlmann M Lauenstein TC Theysohn JM. A singlecenter experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma . Acta Radiol Open 2015 ; 4 : 2047981615570417 . 10.1177/2047981615570417 Open DOISearch in Google Scholar

9. Heusner TA, Antoch G, Wittkowski-Sterczewski A, Ladd SC, Forsting M, Verhagen R, et al. Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment. Rofo 2011; 183: 1151-60. doi: 10.1055/s-0031-1281743 Heusner TA Antoch G Wittkowski-Sterczewski A Ladd SC Forsting M Verhagen R Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment . Rofo 2011 ; 183 : 1151 - 60 . 10.1055/s-0031-1281743 Open DOISearch in Google Scholar

10. Gonsalves CF, Eschelman DJ, Adamo RD, Anne PR, Orloff MM, Terai M, et al. A prospective phase ii trial of radioembolization for treatment of uveal melanoma hepatic metastasis. Radiology 2019; 293: 223-31. doi: 10.1148/radiol.2019190199 Gonsalves CF Eschelman DJ Adamo RD Anne PR Orloff MM Terai M A prospective phase ii trial of radioembolization for treatment of uveal melanoma hepatic metastasis . Radiology 2019 ; 293 : 223 - 31 . 10.1148/radiol.2019190199 Open DOISearch in Google Scholar

11. Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, et al. Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Ann Oncol 2014; 25: 742-6. doi: 10.1093/annonc/mdt585. Leyvraz S Piperno-Neumann S Suciu S Baurain JF Zdzienicki M Testori A Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial . Ann Oncol 2014 ; 25 : 742 - 6 . 10.1093/annonc/mdt585. Open DOISearch in Google Scholar

12. Zimmermann A. Metastatic liver disease: associated liver lesions. In: Zimmermann A, editor. Tumors and tumor-like lesions of the hepatobiliary tract: general and surgical pathology. Cham: Springer International Publishing; 2017. p. 1973-87. Zimmermann A. Metastatic liver disease: associated liver lesions . In: Zimmermann A , editor. Tumors and tumor-like lesions of the hepatobiliary tract: general and surgical pathology . Cham : Springer International Publishing ; 2017 . p. 1973 - 87 . Search in Google Scholar

13. Kromrey M, Ittermann T, Plodeck V, Seppelt D, Hoffmann R, Heiss P, et al. Reference values of liver volume in Caucasian population and factors influencing liver size. Eur J Radiol 2018; 106: 32-7. doi: 10.1016/j. ejrad.2018.07.005 Kromrey M Ittermann T Plodeck V Seppelt D Hoffmann R Heiss P Reference values of liver volume in Caucasian population and factors influencing liver size . Eur J Radiol 2018 ; 106 : 32 - 7 . 10.1016/j.ejrad.2018.07.005 Open DOISearch in Google Scholar

14. Wu C, Ning H, Liu M, Lin J, Luo S, Zhu W, et al. Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis. J Clin Invest 2018; 128: 3425-38. doi: 10.1172/JCI97973 Wu C Ning H Liu M Lin J Luo S Zhu W Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis . J Clin Invest 2018 ; 128 : 3425 - 38 . 10.1172/JCI97973 Open DOISearch in Google Scholar

15. Xiao LS, Hu CY, Cui H, Li RN, Hong C, Li QM, et al. Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors. Cancer Med 2022; 11: 4880-8. doi: 10.1002/cam4.4818 Xiao LS Hu CY Cui H Li RN Hong C Li QM Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors . Cancer Med 2022 ; 11 : 4880 - 8 . 10.1002/cam4.4818 Open DOISearch in Google Scholar

16. Fernández-Placencia R, Golse N, Cano L, Allard MA, Pittau G, Ciacio O, et al. Spleen volumetry and liver transient elastography: predictors of persistent posthepatectomy decompensation in patients with hepatocellular carcinoma. Surgery 2020; 168: 17-24. doi: 10.1016/j.surg.2020.02.009 Fernández-Placencia R Golse N Cano L Allard MA Pittau G Ciacio O Spleen volumetry and liver transient elastography: predictors of persistent posthepatectomy decompensation in patients with hepatocellular carcinoma . Surgery 2020 ; 168 : 17 - 24 . 10.1016/j.surg.2020.02.009 Open DOISearch in Google Scholar

17. Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N. Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol 1997; 7: 246-8. doi: 10.1007/s003300050145 Prassopoulos P Daskalogiannaki M Raissaki M Hatjidakis A Gourtsoyiannis N. Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus . Eur Radiol 1997 ; 7 : 246 - 8 . 10.1007/s003300050145 Open DOISearch in Google Scholar

18. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026 Eisenhauer EA Therasse P Bogaerts J Schwartz LH Sargent D Ford R New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) . Eur J Cancer 2009 ; 45 : 228 - 47 . 10.1016/j.ejca.2008.10.026 Open DOISearch in Google Scholar

19. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, et al. Survival of patents with metastases from uveal melanoma. Ophthalmology 1991; 98: 383-90. doi: 10.1016/s0161-6420(91)32285-1 Gragoudas ES Egan KM Seddon JM Glynn RJ Walsh SM Finn SM Survival of patents with metastases from uveal melanoma . Ophthalmology 1991 ; 98 : 383 - 90 . 10.1016/s0161-6420(91)32285-1 Open DOISearch in Google Scholar

20. Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD. Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol 2017; 11: 279-89. doi: 10.2147/OPTH.S89591 Krantz BA Dave N Komatsubara KM Marr BP Carvajal RD. Uveal melanoma: epidemiology, etiology, and treatment of primary disease . Clin Ophthalmol 2017 ; 11 : 279 - 89 . 10.2147/OPTH.S89591 Open DOISearch in Google Scholar

21. Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003; 44: 4651-9. doi: 10.1167/iovs.03-0538 Kujala E Mäkitie T Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma . Invest Ophthalmol Vis Sci 2003 ; 44 : 4651 - 9 . 10.1167/iovs.03-0538 Open DOISearch in Google Scholar

22. Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz P, et al. Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis. Oncologist 2016; 21: 848-54. doi: 10.1634/theoncologist.2015-0522 Kuk D Shoushtari AN Barker CA Panageas KS Munhoz RR Momtaz P Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis . Oncologist 2016 ; 21 : 848 - 54 . 10.1634/theoncologist.2015-0522 Open DOISearch in Google Scholar

23. Müller L, Kloeckner R, Mähringer-Kunz A, Stoehr F, Düber C, Arnhold G, et al. Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC. Eur Radiol 2022; 32: 6302-13. doi: 10.1007/s00330-022-08737-z Müller L Kloeckner R Mähringer-Kunz A Stoehr F Düber C Arnhold G Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC . Eur Radiol 2022 ; 32 : 6302 - 13 . 10.1007/s00330-022-08737-z Open DOISearch in Google Scholar

24. Müller L, Gairing SJ, Kloeckner R, Foerster F, Weinmann A, Mittler J, et al. Baseline splenic volume outweighs immuno-modulated size changes with regard to survival outcome in patients with hepatocellular carcinoma under immunotherapy. Cancers (Basel) 2022; 14: 3574. doi: 10.3390/cancers14153574 Müller L Gairing SJ Kloeckner R Foerster F Weinmann A Mittler J Baseline splenic volume outweighs immuno-modulated size changes with regard to survival outcome in patients with hepatocellular carcinoma under immunotherapy . Cancers (Basel) 2022 ; 14 : 3574 . 10.3390/cancers14153574 Open DOISearch in Google Scholar

25. Wu WC, Chiou YY, Hung HH, Kao WY, Chou YH, Su CW, et al. Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation. J Clin Gastroenterol 2012; 46: 789-95. doi: 10.1097/MCG.0b013e31825ceeb5 Wu WC Chiou YY Hung HH Kao WY Chou YH Su CW Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation . J Clin Gastroenterol 2012 ; 46 : 789 - 95 . 10.1097/MCG.0b013e31825ceeb5 Open DOISearch in Google Scholar

26. Galland L, Lecuelle J, Favier L, Fraisse C, Lagrange A, Kaderbhai C, et al. Splenic volume as a surrogate marker of immune checkpoint inhibitor efficacy in metastatic non small cell lung cancer. Cancers (Basel) 2021; 13: 3020. doi: 10.3390/cancers13123020 Galland L Lecuelle J Favier L Fraisse C Lagrange A Kaderbhai C Splenic volume as a surrogate marker of immune checkpoint inhibitor efficacy in metastatic non small cell lung cancer . Cancers (Basel) 2021 ; 13 : 3020 . 10.3390/cancers13123020 Open DOISearch in Google Scholar

27. Castagnoli F, Doran S, Lunn J, Minchom A, O’Brien M, Popat S, et al. Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy. PLoS One 2022; 17: e0270950. doi: 10.1371/journal.pone.0270950 Castagnoli F Doran S Lunn J Minchom A O’Brien M Popat S Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy . PLoS One 2022 ; 17 : e0270950 . 10.1371/journal.pone.0270950 Open DOISearch in Google Scholar

28. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmüller G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-8. doi: 10.1038/ki.1993.187 Feucht HE Schneeberger H Hillebrand G Burkhardt K Weiss M Riethmüller G Capillary deposition of C4d complement fragment and early renal graft loss . Kidney Int 1993 ; 43 : 1333 - 8 . 10.1038/ki.1993.187 Open DOISearch in Google Scholar

29. Theophilidou E, Waraich N, Raza T, Agarwal PK. Liver metastases, a rare cause of portal hypertension and stoma bleeding. Brief review of literature. Int J Surg Case Rep 2012; 3: 173-6. doi: 10.1016/j.ijscr.2011.11.008 Theophilidou E Waraich N Raza T Agarwal PK. Liver metastases a rare cause of portal hypertension and stoma bleeding. Brief review of literature . Int J Surg Case Rep 2012 ; 3 : 173 - 6 . 10.1016/j.ijscr.2011.11.008 Open DOISearch in Google Scholar